IDEXX Laboratories
a 3.81 billion USD (FY2024) veterinary diagnostics leader whose reference-lab network and VetConnect Plus software push PCR and antigen results into clinics; in May 2026 it expanded Fecal Dx to taeniid tapeworms including the zoonotic Echinococcus.
- Country
- United States
- Ticker
- IDXX
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ | ✓ |
Regulatorsusda-aphisefsamoa-china
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| One Health — zoonosis & AMR monitoring as a service | diagnostics-medtech | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.